Bimagam 0.03 % 0,3 mg Eye drops
PDF Leaflet Revision Date: 17 October 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Reduction of elevated intraocular pressure in chronic open-angle glaucoma and ocular hypertension.
Dosage (summary)
1 drop in affected eye(s) once daily in the evening.
Onset of Action / Duration
Onset: 4 hours, Duration: 24 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding due to unknown safety.
Key Drug Interactions
- Other prostaglandin analogues may reduce IOP-lowering effect
Contraindications
- Hypersensitivity to bimatoprost or benzalkonium chloride
Common side effects
- Eyelash growth
- Conjunctival hyperemia
- Ocular pruritus
Counselling Points
- Avoid contact with skin to prevent hair growth
- Remove contact lenses before use
Serious warnings
- Potential for permanent iris pigmentation
- Caution in patients with respiratory issues
Important Disclaimer
The Bimagam 0.03 % 0,3 mg Eye drops professional information leaflet below is the property of Austell Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
